{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:26:40Z","timestamp":1785331600139,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12029-022-00843-x","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T19:02:36Z","timestamp":1656702156000},"page":"632-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis"],"prefix":"10.1007","volume":"54","author":[{"given":"Fatah","family":"Tidadini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Trilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Bonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Faucheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6674-799X","authenticated-orcid":false,"given":"Catherine","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"issue":"1","key":"843_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3978\/j.issn.2078-6891.2015.112","volume":"7","author":"A Dehal","year":"2016","unstructured":"Dehal A, Smith JJ, Nash GM. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol. 2016;7(1):143\u201357. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.112.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"843_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319. https:\/\/doi.org\/10.1016\/S1470-2045(16)30500-9.","journal-title":"Lancet Oncol"},{"issue":"23","key":"843_CR3","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028\u201340. https:\/\/doi.org\/10.1200\/JCO.18.01688.","journal-title":"J Clin Oncol"},{"issue":"3","key":"843_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1708618.","journal-title":"N Engl J Med"},{"issue":"7","key":"843_CR5","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26(7):1849\u201355. https:\/\/doi.org\/10.1007\/s00464-012-2148-0.","journal-title":"Surg Endosc"},{"issue":"3","key":"843_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/pp-2016-0017","volume":"1","author":"V Khomyakov","year":"2016","unstructured":"Khomyakov V, Ryabov A, Ivanov A, et al. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2). Pleura Peritoneum. 2016;1(3):159\u201366. https:\/\/doi.org\/10.1515\/pp-2016-0017.","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"843_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg. 2016;20(2):367\u201373. https:\/\/doi.org\/10.1007\/s11605-015-2995-9.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"843_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W, et al. Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol. 2014;132(2):307\u201311. https:\/\/doi.org\/10.1016\/j.ygyno.2013.11.022.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"843_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Solass W, et al. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol. 2015;137(2):223\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.009.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"843_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtr\u00f6der","year":"2016","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016;18(4):364\u201371. https:\/\/doi.org\/10.1111\/codi.13130.","journal-title":"Colorectal Dis"},{"issue":"5","key":"843_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","volume":"34","author":"M Graversen","year":"2017","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. 2017;34(5):309\u201314. https:\/\/doi.org\/10.1007\/s10585-017-9849-7.","journal-title":"Clin Exp Metastasis"},{"issue":"10","key":"843_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186709","volume":"12","author":"T Khosrawipour","year":"2017","unstructured":"Khosrawipour T, Khosrawipour V, Giger-Pabst U. Pressurized intra peritoneal aerosol chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS ONE. 2017;12(10): e0186709. https:\/\/doi.org\/10.1371\/journal.pone.0186709.","journal-title":"PLoS ONE"},{"issue":"1","key":"843_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.21873\/anticanres.12232","volume":"38","author":"TA Falkenstein","year":"2018","unstructured":"Falkenstein TA, G\u00f6tze TO, Ouaissi M, Tempfer CB, Giger-Pabst U, Demtr\u00f6der C. First clinical data of pressurized intraperitoneal aerosol chemotherapy (PIPAC) as salvage therapy for peritoneal metastatic biliary tract cancer. Anticancer Res. 2018;38(1):373\u20138. https:\/\/doi.org\/10.21873\/anticanres.12232.","journal-title":"Anticancer Res"},{"key":"843_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00698-8","author":"F Tidadini","year":"2021","unstructured":"Tidadini F, Abba J, Quesada JL, et al. Effect of pressurized intraperitoneal aerosol chemotherapy on the survival rate of patients with peritoneal carcinomatosis of gastric origin. J Gastrointest Canc. 2021. https:\/\/doi.org\/10.1007\/s12029-021-00698-8.","journal-title":"J Gastrointest Canc"},{"issue":"1","key":"843_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47(1):123\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.021.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"843_CR16","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368\u201377. https:\/\/doi.org\/10.1016\/S1470-2045(19)30318-3.","journal-title":"Lancet Oncol"},{"key":"843_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23.","journal-title":"Cancer Treat Res"},{"issue":"12","key":"843_CR18","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.ejso.2020.05.007","volume":"46","author":"M Alyami","year":"2020","unstructured":"Alyami M, Sgarbura O, Khomyakov V, et al. Standardizing training for pressurized intraperitoneal aerosol chemotherapy. Eur J Surg Oncol. 2020;46(12):2270\u20135. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.007.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"843_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21(2):553\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3213-1.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"843_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","volume":"18","author":"I Gockel","year":"2018","unstructured":"Gockel I, Jansen-Winkeln B, Haase L, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study. J Gastric Cancer. 2018;18(4):379\u201391. https:\/\/doi.org\/10.5230\/jgc.2018.18.e37.","journal-title":"J Gastric Cancer"},{"issue":"2","key":"843_CR21","doi-asserted-by":"publisher","first-page":"20200109","DOI":"10.1515\/pp-2020-0109","volume":"5","author":"SB Elleb\u00e6k","year":"2020","unstructured":"Elleb\u00e6k SB, Graversen M, Detlefsen S, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum. 2020;5(2):20200109. https:\/\/doi.org\/10.1515\/pp-2020-0109.","journal-title":"Pleura Peritoneum"},{"issue":"3","key":"843_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622\u20138. https:\/\/doi.org\/10.1002\/ijc.28373.","journal-title":"Int J Cancer"},{"issue":"12","key":"843_CR23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02274.x.","journal-title":"Br J Surg"},{"issue":"5","key":"843_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27(5):681\u20135. https:\/\/doi.org\/10.1200\/JCO.2008.19.7160.","journal-title":"J Clin Oncol"},{"issue":"10","key":"843_CR25","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/annonc\/mds203","volume":"23","author":"LC Hanker","year":"2012","unstructured":"Hanker LC, Loibl S, Burchardi N, et al. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane\/platinum-based therapy. Ann Oncol. 2012;23(10):2605\u201312.","journal-title":"Ann Oncol"},{"issue":"2","key":"843_CR26","doi-asserted-by":"publisher","first-page":"20180116","DOI":"10.1515\/pp-2018-0116","volume":"3","author":"C Eveno","year":"2018","unstructured":"Eveno C, Jouvin I, Pocard M. PIPAC EstoK 01: pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study. Pleura Peritoneum. 2018;3(2):20180116. https:\/\/doi.org\/10.1515\/pp-2018-0116.","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"843_CR27","doi-asserted-by":"publisher","first-page":"20180113","DOI":"10.1515\/pp-2018-0113","volume":"3","author":"T Oliver Goetze","year":"2018","unstructured":"Oliver Goetze T, Al-Batran SE, Pabst U, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo na\u00efve upper gi-adenocarcinomas with peritoneal seeding - a phase II\/III trial of the AIO\/CAOGI\/ACO. Pleura Peritoneum. 2018;3(2):20180113. https:\/\/doi.org\/10.1515\/pp-2018-0113.","journal-title":"Pleura Peritoneum"},{"key":"843_CR28","unstructured":"History of Changes for Study: NCT04811703. https:\/\/www.clinicaltrials.gov\/ct2\/history\/NCT04811703?V_1=View. Accessed 10 May\u00a02022."}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00843-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-022-00843-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00843-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:39:11Z","timestamp":1692247151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-022-00843-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1007\/s12029-022-00843-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"11 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards research committee and with the Helsinki declaration. The study was registered in the internal register of the Grenoble Alpes University Hospital of studies respecting the reference methodology MR004 of the French National Commission for Informatics and Freedoms (CNIL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Patients were informed that their anonymized data might in the future be the subject of clinical research and could oppose this by informing the doctor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}